Pop Test Oncology/Palisades Therapeutics Press Releases - EIN Presswire

Published on May 17, 2022 - 13:45 GMT

Palisades Therapeutics PT150 for treatment of “long haul COVID” neuro-psychiatric conditions

PT150 for depression, fatigue, memory dysfunction, and “brain fog” associated with long haul COVID syndrome CLIFFSIDE PARK, NJ, UNITED STATES, May 17, 2022 /⁨EINPresswire.com⁩/ -- Neuroinflammatory changes have been implicated in long haul COVID syndrome, …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on March 1, 2022 - 15:00 GMT

Palisades Therapeutics Targets the IHOP Protein as a Biomarker to Detect Pancreatic Cancer and Enable PT Therapeutic

A collaborative effort between Palisades Therapeutics and Georgetown University could produce a pancreatic cancer breakthrough CLIFFSIDE PARK, NJ, UNITED STATES, March 1, 2022 /⁨EINPresswire.com⁩/ -- Early detection is key to life saving treatments for …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on February 22, 2022 - 15:00 GMT

Palisades Therapeutics’ Proprietary Dual Action Compound Reduces COVID-19 Viral Entry and Inflammatory Responses

Post-exposure prophylaxis for prevention of COVID-19 Acute Respiratory Distress Syndrome (ARDS) CLIFFSIDE PARK, NJ, UNITED STATES, February 22, 2022 /⁨EINPresswire.com⁩/ -- Palisades Therapeutics, working in collaboration with Prof. Richard Slayden and …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on February 15, 2022 - 15:00 GMT

Proprietary Dual Action Compound Could Save the Citrus Industry from Citrus Greening Plague

PT Compounds as a Method of Eradicating Citrus Greening and For Disrupting the Citrus Greening Life Cycle CLIFFSIDE PARK, NJ, UNITED STATES, February 15, 2022 /⁨EINPresswire.com⁩/ -- Palisades Therapeutics, working in collaboration with Central State …

Distribution channels: Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry ...

Published on January 18, 2022 - 15:00 GMT

Palisades Therapeutics Drug Platform Demonstrates Reduction in Neuroinflammation Across Three Species

FDA IND assigned for Neurodegeneration to Palisades Therapeutics CLIFFSIDE PARK, NEW JERSEY, USA, January 18, 2022 /⁨EINPresswire.com⁩/ -- Reduction in neuroinflammation demonstrated in three species –mice, rats and hamsters- all consistent results. The …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on January 6, 2022 - 15:00 GMT

PALISADES THERAPEUTICS ANNOUNCES A NEWLY PATENTED NOVEL APPROACH THAT COULD BE KEY TO STOPPING COVID AND OTHER VIRUSES

Palisades Therapeutics Wins the COVID Patent Race!!! CLIFFSIDE PARK, NEW JERSEY, USA, January 6, 2022 /⁨EINPresswire.com⁩/ -- Palisades Therapeutics has been granted a Patent for a broad-spectrum platform of new molecules to be positioned alone or in …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...